First Commonwealth Financial Corp PA Makes New $210,000 Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD) Coverage Initiated at Cantor Fitzgerald

Cantor Fitzgerald started coverage on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a research note published on Tuesday, Marketbeat.com reports. The brokerage issued an overweight rating and a $125.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald also issued estimates for Gilead Sciences’ FY2025 earnings at $7.93 EPS. Several other brokerages have […]

Capital Research Global Investors Sells 3,853,443 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Capital Research Global Investors trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 6.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 57,946,228 shares of the biopharmaceutical company’s stock after selling 3,853,443 shares during […]

First Commonwealth Financial Corp PA Makes New $210,000 Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

First Commonwealth Financial Corp PA purchased a new position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,269 shares of the biopharmaceutical company’s stock, valued at approximately $210,000. Several other institutional investors also […]